RE: tom oakley - proactive11 Jul 2019 15:21
This could be massive! i have to say that despite my initial concern at the change in direction, this seems like an excellent move to tap in to a massive market and solve a major need, NOW. Very excited with the american opportunities too. About time we had a positive update. I love the fact that he will be evaluating Texrad and re positioning it to also become a clinical tool. That's more like it guys! the market is completely down on this so a great opportunity to add on the cheap IMO. :)